David Sebag-Montefiore, Director at Leeds Cancer Research UK Radiotherapy Research Centre of Excellence, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical Oncology:
“Fantastic to see ‘Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at the Cancer Research UK Leeds Clinical Trial Unit’ published.”
A portfolio of 9 funded trials including 14 studies evaluating radiotherapy dose, novel technology and novel agent drug combinations, funded and supported by Cancer Research UK (CRUK), NIHR (National Institute for Health and Care Research), Medical Research Council, Yorkshire Cancer Research, Adlai Nortye, AstraZeneca, The Brain Tumour Charity, and Jon Moulton.
Very proud of our radiotherapy research team that spans Leeds Clinical Trials Research Unit (Leeds CTRU) and Leeds Cancer Research UK (CRUK) Radiation Research Centre of Excellence at University of Leeds.”
Title: Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer Research UK Clinical Trials Unit
Authors: F. Slevin, E.M. Hudson, A. Hockaday, J. Kendall, S. Noutch, J.B. Oughton, A. Smith, J.C. Webster, D. Sebag-Montefiore, S.R. Brown
Read the Full Article on Clinical Oncology
More posts featuring David Sebag-Montefiore.
